This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration. Need a new registration confirmation email? Click here
The report is built using data and information sourced from proprietary databases, primary and secondary research, and in-house analysis by a team of industry experts.
The sickle cell anemia market will be the fastest growing of the three markets during the forecast period with a Compound Annual Growth Rate (CAGR) of 9% seeing it reach $70m in 2019. The thalassemia market will grow at a lower CAGR of 7% to reach $59m in 2019. HAE represents the largest but slowest growing market, expected to reach $1.89 billion by 2019 at a CAGR of 3%.
- Current and future treatment trends for three rare diseases
- Market forecasts for three rare diseases across seven major markets
- Analysis of the developmental pipelines for three rare diseases
- Information on recent industry deals
Reasons to buy
- Understand how the inherited orphan blood diseases market has developed and is continuing to develop within the featured markets
- Predict which products are likely to be most successful in the future
- Gain an understanding of the possible market available for specific products
For more information visithttp://www.researchandmarkets.com/research/ktwc9z/inherited_orphan.